VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO Immuno-Oncology 2022 | Addressing and overcoming limitations in cancer vaccines

Michael Nishimura, PhD, Loyola University Chicago, Chicago, IL, provides an overview of challenges associated with cancer vaccines in solid tumors. The immunosuppressive nature of the tumor microenvironment limits the efficacy of cancer vaccines, especially with the presence of neoantigens. Strategies including combining cancer vaccines with existing checkpoint inhibitors are needed to overcome the hostile environment. This interview took place at the ESMO Immuno-Oncology Congress 2022 in Geneva, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter